A Phase 1/2 interventional study of Cells in Silicosis, sponsored by Wei Yu. Completed. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2013-11-25.
Sponsored by Wei Yu · Phase 1/2, Interventional, and Treatment
The aim of this study was to analyze the safety, pulmonary function, and imaging changes of patients with silicosis treated with autologous bone marrow stromal cells with modification by hepatocyte growth factor.
20 studies on the registry are indexed under Silicosis; 3 are open to participants now.
Browse Silicosis studies →This is the only study on the registry with Wei Yu as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
FEV1
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Cells
Absence of lung deficits during the procedure and/or in the 6 months follow-up
Time frame: 6 months
Improvement of pulmonary deficits
Time frame: 1 year
No study locations are listed for this record.
This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.